One Nucleus presents Genesis 2024
December 3, 2024
Pharmidex
is thrilled to announce that
Ash Alavijeh, our Head of Operations, will attend the "Maximising Returns from Life Science Innovation" conference by One Nucleus on 4 December 2024, at 1 Wimpole Street, London, UK (https://lnkd.in/ea5abEEQ).
This dynamic event is a fantastic opportunity to explore life science breakthroughs and connect with industry leaders.
Ash is excited to meet attendees, exchange ideas, and discuss ways to innovate together. Don’t miss the chance to say hello!
#Pharmidex #LifeScienceInnovation #Networking #GenesisConference
We’re excited to welcome Grace Horne as our new Bioanalytical Scientist! 🎉 Grace brings great enthusiasm and passion for science, and we’re confident she’ll make a fantastic contribution to our team. Welcome aboard, Grace, we’re thrilled to have you with us! 💜
We’re pleased to share that Janette Dalay Robertson , Business Development Manager at Pharmidex , will attend the DDW Turning Science into Business Symposium 2025 on Tuesday, 4th November, at the The Francis Crick Institute , London. Janette looks forward to connecting with industry leaders and exploring new collaboration opportunities.
We’re delighted to announce that Pharmidex will present our poster "Driving breakthroughs in Parkinson’s & neurodegeneration research” at the upcoming RSC BMCS meeting. With over 23 years of CNS expertise, we support biopharma partners in developing new therapies for Parkinson’s disease and tauopathies, through: 🔹 Parkinson’s & neurodegeneration models 🔹 Transgenic CNS lines (incl. 5xFAD) 🔹 Biomarker & BBB penetration studies Join us in Cambridge to explore how our GLP-accredited CNS platforms accelerate discovery and development.
